Analytic Investors’s NEOPHOTONICS CORP NPTN Stock Holding History

Analytic Investors’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-33,152	Closed	-$316K	–	701
2016 Q2	$316K	Sell	33,152 -98,325	-75%	-$1.07M	﹤0.01%	526
2016 Q1	$1.85M	Buy	131,477 +48,644	+59%	+$503K	0.02%	316
2015 Q4	$900K	Buy	82,833 +13,190	+19%	+$119K	0.01%	411
2015 Q3	$474K	Buy	+69,643	New	+$539K	0.01%	461

Other funds holding NPTN

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Analytic Investors's NPTN Position: Q3 2016 in Review

Analytic Investors sold out of NEOPHOTONICS CORP (NPTN) in Q3 2016, closing a stake of 33,152 shares — an estimated $316K sold.

Analytic Investors first reported a position in NPTN in Q3 2015 and held it in 4 quarters. The position peaked at $1.85M in Q1 2016. 147 funds tracked by Wall St. Rank hold NPTN as of Q3 2016.

Analytic Investors reported no remaining NEOPHOTONICS CORP position as of Q3 2016 after selling out during the quarter.
Analytic Investors sold 33,152 NEOPHOTONICS CORP shares in Q3 2016, an estimated $316K.
Analytic Investors first reported a position in NEOPHOTONICS CORP in Q3 2015 and held it in 4 quarters.
Analytic Investors's NEOPHOTONICS CORP position peaked at $1.85M in Q1 2016.
147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.